🥳🥳Thrilled to celebrate these outstanding surgeons, including our breast surgery fellow @AnnaLouieMD!! 🤩🤩 #futureisbright 🌟🔥☀️ Also proud to work with these incredible surgeons and colleagues at Duke, pictured here with our fellow ☺️
Last Friday we celebrated 3️⃣ incredible fellows completing training in surg onc, endocrine surgery, & breast surg onc—a night well deserved at @VinRougeDurham! 🎉
Congrats to Drs. Sullivan, Trone, & Louie! You are all dedicated, skilled & compassionate surgeons. 👏🏼🔪
The impact of #ISW26Mexico continues!
2,484 participants | 98 countries | 141 scientific sessions | 1,185 abstracts
Thank you to our speakers, presenters, delegates, partners, & volunteers for making ISW2026 a global platform for surgical collaboration.
#ISSSIC#GlobalSurgery #
On this #FoundationFriday, we want to highlight the AWS Awards Dinner and Gala, held on Sunday, September 27 in Washington DC, our most highly-anticipated event of the year. Book your tickets and tables here: bit.ly/2026AWSFGala
Host the 2026-2027 LSS AWS Visiting Professor, Dr. Helen Johnson! @LatinoSurgery and AWS are pleased to announce their annual visiting professorship program. Applications to host Dr. Helen M. Johnson, are open and close on July 29. Apply Here: bit.ly/AWSLSSHOST
A patient came to the Rogel Cancer Center looking for answers to treat her rare neuroendocrine tumor.
Alongside a multidisciplinary care team, Evan Glazer, MD, PhD, came up with a personalized treatment plan.
The full story: michmed.org/9ZkwP
ALT A couple wearing matching plaid shirts and jeans poses on the front steps of a brick house with three dogs.
The AWS Fellowship Grant application is due in 2 days! Secure $20K to support your clinical, pre-clinical, translational, or educational research project.
Learn more and apply here: bit.ly/awsfellowshipgrant
Tremendous honor to be the graduation speaker for the NCI Surgical Oncology Branch and NCI Surgery Branch last week. The research continues to set the pace for our field and the graduating fellows showed me that the future is in good hands. @NCI_SurgOncFel@NCICCR_SurgOnc
This June 7, we honor cancer survivors—their strength, resilience, and stories inspire us every day. At SSO, we’re proud to support lifelong survivorship through innovation, compassion, and excellence in surgical oncology 🎗.
#CancerSurvivorsDay#SSO
AWS Shining Star Leadership Coaching applications close in 3 days! Junior women surgeons have the grow their leadership skills in this cohort. AWS members with 5 years of being a practicing surgeon are eligible.
Learn more and apply here: bit.ly/AWSShiningStar💫
#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!
While at #ASCO26, Zeynep Eroglu, MD, stopped by the booth to discuss research exploring adaptive treatment approaches in advanced BRAF V600E-mutant melanoma, using ctDNA, imaging and patient-specific treatment strategies to help guide therapy decisions. #MoffittASCO26
While at #ASCO26, Nikhil Khushalani, MD (@DrKhushalani), and Zeynep Eroglu, MD, discuss promising advances in uveal melanoma, including a potentially practice-changing trial evaluating darovasertib in patients with HLA-A2-negative metastatic disease.
The study demonstrated a substantial improvement in progression-free survival and offers hope for a patient population with limited treatment options. #MoffittASCO26
From groundbreaking research to practice-changing data, #ASCO26 highlighted the progress being made across the cancer continuum.
Moffitt experts were proud to join nearly 50,000 oncology professionals from around the world to share research and help drive progress for patients.
Explore Moffitt's meeting highlights at moffitt.org/ASCO.
See you in Chicago for #ASCO27!
#MoffittASCO26
At #ASCO26, Nikhil Khushalani, MD (@DrKhushalani), and Lilit Karapetyan, MD (@KarapetLilit), discuss advances in TIL therapy for melanoma.
Their conversation highlights research on the tumor microenvironment and collaborative efforts to better understand treatment-related toxicities, including cytopenias and infections, with the goal of optimizing patient selection and improving outcomes. #MoffittASCO26